Glucosyltransferase 1 deficiency (Q94035): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(4 intermediate revisions by the same user not shown)
Property / CURIE
 
CID11:ID_603963810
Property / CURIE: CID11:ID_603963810 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_603963810
Property / Canary Token: dki-india-ID_603963810 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 09:09, 16 August 2026

The CDG (Congenital Disorders of Glycosylation) syndromes are a group of autosomal recessive disorders affecting glycoprotein synthesis. CDG syndrome type Ic is characterised by psychomotor delay and muscular hypotonia. It has been described in more than 30 individuals so far. Hepatic and intestinal manifestations were also often reported. Coagulation anomalies, hormonal abnormalities and seizures may also be present and life-threatening. The syndrome is caused by mutations in the ALG6 gene (localised to the q22.3 region of chromosome 1) leading to a deficiency of the endoplasmic reticulum enzyme alpha1,3-glucosyltransferase.
Language Label Description Also known as
default for all languages
ID_603963810
    English
    Glucosyltransferase 1 deficiency
    The CDG (Congenital Disorders of Glycosylation) syndromes are a group of autosomal recessive disorders affecting glycoprotein synthesis. CDG syndrome type Ic is characterised by psychomotor delay and muscular hypotonia. It has been described in more than 30 individuals so far. Hepatic and intestinal manifestations were also often reported. Coagulation anomalies, hormonal abnormalities and seizures may also be present and life-threatening. The syndrome is caused by mutations in the ALG6 gene (localised to the q22.3 region of chromosome 1) leading to a deficiency of the endoplasmic reticulum enzyme alpha1,3-glucosyltransferase.

      Statements

      CID11:ID_603963810
      0 references
      dki-india-ID_603963810
      0 references
      Concluído
      0 references
      15 August 2026
      0 references